Best Beta Cells Podcasts (2026)

1
Diabetes Core Update Jan 2026 26:54

Play Pause

1h ago26:54

26:54

This issue will review: 1. Evolocumab in Patients without a Previous Myocardial Infarction or Stroke 2. SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria 3. Continuous SGLT-2, GLIP-1RA and Frailty Progression in Older Adults with Type 2 Diabetes 4. Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Sta…

1
Best of Patreon 2025! 49:42

4d ago49:42

49:42

Happy new year! We'll be back next week, but to tide you over until then we're giving you a peek behind the paywall with some of the best bits from Patreon! Hear what happens when we get sidetracked during our Dateline Recaps and This New Thing We're Doing! with some of our favorite moments from 2025. For hundreds of hours of bonus content and vide…

1
PulseCast: Highlights in MDS/MPNs From the 2025 ASH Annual Meeting 14:59

7d ago14:59

14:59

In this podcast episode, Rami Komrokji, MD, reviews data from select presentations in myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) presented at the ASH 2025 Annual Meeting and shares expert perspectives on the clinical implications of these findings, including: Abstract 910: MANIFEST-2 96-Wk Update: Ruxolitinib + Pelabres…

1
Experts Discuss CELMoD Agents for Treating Multiple Myeloma 17:30

7d ago17:30

17:30

In this podcast episode, Jesus Berdeja, MD; Amrita Krishnan, MD, FACP; and Niels van de Donk, MD, PhD, address key questions on CELMoD agent therapy for multiple myeloma, including: Combination strategies Adverse event management Where CELMoD agents may best fit within current and future treatment strategies Presenters: Jesus Berdeja, MD Director o…

1
Special Edition- Weight Bias and Stigma – Part 1 38:27

1h ago38:27

38:27

In this special series on Weight Bias and Stigma our host, Dr. Neil Skolnik will discuss weight bias and stigma and its importance because weight bias and stigma have an important impact the experience of living with obesity, leads to measurable adverse outcomes, and when it is present in health care interactions it affects all subsequent care that…

1
Best of 2025! 1:57:01

3h ago1:57:01

1:57:01

Happy Holidays to all our listeners! We're off this week but have compiled some of the best bits from the year for your listening pleasure. We hope we've been entertaining and informative and that you'll join us again in 2026! Our Patreon bonus episodes continue through the holidays! For more content visit www.patreon.com/attitudes See omnystudio.c…

1
Expert Highlights From the 2025 World Conference on Lung Cancer 24:30

12d ago24:30

24:30

In this episode, Dr John Heymach and Dr Solange Peters discuss key data presented at the IASLC World Conference on Lung Cancer including first-line maintenance in ES-SCLC (IMforte and DeLLphi-303 trials) and targeted treatment for NSCLC (FLAURA2, Beamion LUNG-1, and ARROS-1 trials). Presenters: John Heymach, MD, PhD Chair and Professor Department o…

1
PulseCast: Highlights in Multiple Myeloma From the 2025 ASH Annual Meeting 15:45

13d ago15:45

15:45

In this episode, Shaji K. Kumar, MD, reviews key highlights from ASH 2025 in multiple myeloma (MM), focusing on emerging data for bispecific antibodies and CAR T-cell therapies across earlier and later lines of treatment. The discussion covers the following: MajesTEC-3: Results from the phase III study of teclistamab + daratumumab in R/R MM Redirec…

1
PulseCast: Highlights in Lymphomas From the 2025 ASH Annual Meeting 14:25

17d ago14:25

14:25

In this podcast episode, Jeremy S. Abramson, MD, MMSc, reviews data from select presentations in lymphomas at the ASH 2025 Annual Meeting and provides perspectives on the clinical implications of these data for patients with chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL), including: CLL17: ra…

1
PulseCast: Highlights in Nonmalignant Blood Disorders From the 2025 ASH Annual Meeting 17:39

18d ago17:39

17:39

In this episode, Hanny Al-Samkari, MD, gives his thoughts on 5 key presentations from ASH 2025, and provides perspectives on the clinical implications of these data for patients with nonmalignant hematologic disorders such as ITP and vWD, including: LBA-2: Primary results from VAYHIT2, a randomized, double-blind, phase III trial of ianalumab plus e…

1
Special Edition: What's Next: Adherence to Medications – Challenges and (some) Solutions December 2025 26:02

7d ago26:02

26:02

In this special edition on Adherence to Medications our host, Dr. Neil Skolnik will discuss medication adherence and the role of clinicians, pharmacies and pharmacists in helping with medication adherence. This special episode is supported by an independent educational grant from Amazon. Presented by: Neil Skolnik, M.D., Professor of Family and Com…

1
The 2025 Holiday Spectacular! 1:54:45

19d ago1:54:45

1:54:45

We're happy to bring back our annual tradition of welcoming some of our favorites into our holiday home before the winter break! Punam Patel reveals what underrated department store she purchased her outfit from at a local dead mall, Pete Zias tells the tale of a stolen Labubu , Darby and Alexis from IMHO: The Show are taking Metamucil gummies to s…

1
PulseCast: Highlights in Leukemias From the 2025 ASH Annual Meeting 22:20

19d ago22:20

22:20

In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspectives on the clinical implications of these data for patients with acute myeloid leukemia (AML) or chronic myeloid leukemia (CML), including: Abstract 6: Phase II PARADIGM trial of azacitidine and venet…

1
Special Edition: MASH Part 2 – Diagnosis and Treatment – December 2025 32:13

10d ago32:13

32:13

In this special series on Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-associated steatohepatitis (MASH) our host, Dr. Neil Skolnik will discuss Epidemiology, Importance, Screening, Diagnosis and Treatment of MASH. This special episode is supported by an independent educational grant from Boehringer Ing…

1
LinkedIn Algorithm, Lavender Scare, Bad Haircuts and Truffle Pigs 57:05

26d ago57:05

57:05

This week Bryan is upset over his short haircut, and Erin's back from her trip to Italy where she got her fill of truffles and was made fun of by flight attendants because of her hairstyle. Erin covers how women are exposing the "bro-coding" algorithm on LinkedIn by changing their gender marker from female to male and seeing an increase in their re…

1
Special Edition - Automated Insulin Delivery - Part 1 31:37

16d ago31:37

31:37

In this special series on Automated Insulin Delivery our host, Dr. Neil Skolnik will discuss with Davida Kruger the benefits of Automated Insulin Delivery for people with Type 2 Diabetes. This special episode is supported by an independent educational grant from Insulet. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, …

1
Bergman on altering lipid localization and adipose tissue cellular composition through weight loss and exercise, Walters, Castro-Gutierrez, Mukherjee & Russ on HLA immune presentation on Human β-Cells ... 1:35:17

1M ago1:35:17

1:35:17

Welcome to the December 2025 episode of DiabetesBio—the American Diabetes Association's podcast for its flagship research publication, Diabetes. In this episode of DiabetesBio, Drs. Kirk Habegger, Darleen Sandoval, and Kevin Williams discuss the latest and greatest content in the December 2025 issue of Diabetes. 13:10 After discussing their favorit…

1
Same Sex Marriage Rulings in Japan and the EU, Rockettes and the American Girl Doll Store with Guest Host Naomi Ekperigin! 54:52

1M ago54:52

54:52

While Erin is out of town Bryan is joined by friend of the show Naomi Ekperigin this week! We discuss what we did for Thanksgiving, and how Bryan spent last week with his family doing a tour of NYC including the Radio City Christmas Spectacular and an investigative report on how the American Girl Doll Store is one big scam. Bryan covers a recent ru…

1
Dateline Recap: The Prince, The Whiz Kid & The Millionaire 52:06

1M ago52:06

52:06

Happy Thanksgiving! We're off this week but we wanted to share one of our recent favorite Dateline Recaps from behind the paywall! Palm Springs, big hair, adult film stars, celebrities, and an iconic local journalist who we'd marry in a heartbeat. The gayest Dateline we've ever covered. Dateline Season 34, Episode 3. A group of conspirators, includ…

1
Diabetes Core Update – December 2025 33:31

30d ago33:31

33:31

This issue will review: 1. Screening Natriuretic Peptide Levels Predict Heart Failure and Mortality in Individuals with Type 1 and Type 2 Diabetes without Known Heart Failure 2. The Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications In Patients with Type 2 Diabetes 3. Continuous Glucose Monitoring Frequency…

1
Gay Marriage Support in Decline, Menopause Treatment Changes, Cigarettes and Books from the 1930s 1:06:21

2M ago1:06:21

1:06:21

This week Erin shares her new hobby of reading rare books from the 1930s, and Bryan gets back to smoking on the set of a short film in New York. Bryan covers annual polls from YouGov/The Economist and Gallup showing support for gay marriage and trans rights is at its lowest level in the last 10 years. Erin discusses how the NHS in the UK is now inc…

1
Special Edition - CVOTs Part 2 34:42

2M ago34:42

34:42

In this special series on The Cardiovascular Outcome Trials our host, Dr. Neil Skolnik will discuss the history and importance of the Cardiovascular Outcome Trials for diabetes medications. In Part 1 we discussed an historical perspective with Dr. Steven Nissen. Today we discuss with Dr. Darren McGuire the incredible evolution of the CVOTs since th…

1
TROP2 and TIGIT Therapies for Advanced NSCLC: Where Are We Today? 20:37

2M ago20:37

20:37

In this episode, Benjamin Levy, MD, FASCO, and Alex Spira, MD, PhD, FASCO, discuss the latest developments in targeting TROP2 and TIGIT for the treatment of lung cancer, including: TROP2-targeting ADCs: datopotamab deruxtecan, sacituzumab govitecan, sacituzumab tirumotecan TROP2 ADCS for patients with EGFR-mutated NSCLC TIGIT-targeting agents: domv…

1
New York Times Blaming Women in the Workplace, Kim Davis’ Supreme Court Defeat, Austin, Erewhon Smoothies and Digi-Annie 1:13:55

2M ago1:13:55

1:13:55

Erin is dehydrated after her visit to Austin, Bryan befriends his Erewhon-going seatmates on a flight to New York, plus some balm/SPF talk and a celebration of the results from last week’s elections. Erin discusses the NYT Opinion interview with three feminist conservative bootlickers titled “Did Liberal Feminism Ruin the Workplace”. Bryan brings u…

1
Special Edition: What's Next—An Update on Beta Cell Function 31:09

2M ago31:09

31:09

In this special episode on a Beta Cell Update Dr. Neil Skolnik discusses this emerging area with Dr. Melena Bellin. This special episode is supported by an independent educational grant from Sanofi. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Dir…

1
Kaylia Reynolds and Nora Franceschini on diabetes genetic clusters, Stephanie Holm & Christoffer Clemmensen on sustained weight loss with LEAP2 & Semaglutide, plus "Sweet Talk" with Banting Medal recipient ... 1:06:37

2M ago1:06:37

1:06:37

Welcome to the November 2025 episode of DiabetesBio—the American Diabetes Association's podcast for its flagship research publication, Diabetes. In this episode of DiabetesBio, Drs. Kirk Habegger, Darleen Sandoval, and Kevin Williams discuss the latest and greatest content in the November 2025 issue of Diabetes. 6:00 In the first segment, our hosts…

1
A Newly Approved Targeted Combination Therapy for KRAS-Mutant Low-Grade Serous Ovarian Cancer 22:14

2M ago22:14

22:14

In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent research has transformed the therapeutic landscape for these patients, including: Molecular distinctions between low-grade and high-grade serous ovarian cancer that can guide therapy selection The rec…

1
Javier Milei, Gender Pay Gap Widening, Slow Horses and Great Aunt Tiny 54:37

2M ago54:37

54:37

This week Erin goes horseback riding which causes Bryan's childhood equine trauma to resurface. Bryan discusses Argentinian President Javier Milei's Trump-style crusade against "LGBTQ+ ideology" and his ban on gender affirming care. Erin covers the gender pay gap which has widened for a second year in a row due to women being forced back into the o…

1
CDH6-Targeting Antibody–Drug Conjugates in Ovarian Cancer: A Promising Treatment Approach 26:01

2M ago26:01

26:01

In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conjugates (ADCs) for ovarian cancer, including: Results of the phase I trial of raludotatug deruxtecan (R-DXd) in ovarian cancer Results of the phase II REJOICE-Ovarian01 study in patients with platinum-re…

1
Diabetes Core Update Nov 2025 27:46

2M ago27:46

27:46

This issue will review: 1. Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis - Diabetes Care 2. Orforglipron, an Oral Small-Molecule GLP-1Receptor Agonist, in Early Type 2 Diabetes – NEJM 3. Orforg…

1
Transforming Care in Cutaneous Squamous Cell Carcinoma: Integrating Immunotherapy Into Patient Care 35:16

2M ago35:16

35:16

In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for cutaneous squamous cell carcinoma (cSCC) based on key data from pivotal studies that are reshaping standards of care, including: Trials of neoadjuvant immunotherapies demonstrating remarkable response…

1
Female World Leaders, Newsom Bill Vetos, and a Happy Hallowqueen! 1:00:51

2M ago1:00:51

1:00:51

It's All Hallows' Eve and Erin and Bryan are dressed as everyone's favorite 90s home decorator and TV psychic for the occasion. Plus, everyone's favorite game - spin that wig! Erin shines a spotlight on two world leaders on opposite ends of the political spectrum: Prime Minister Sanae Takaichi who is shepherding a new wave of conservatism in Japan,…

1
Paroxysmal Nocturnal Hemoglobinuria: Translating Pathobiology Into Modern Clinical Management 27:48

2M ago27:48

27:48

In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal hemoglobinuria (PNH). They trace the evolution of treatment from early complement inhibitors to today’s expanding therapeutic options, emphasizing how these advances have transformed patient outcomes …

1
Special Episode 8: Steve Chapman, Andrew Hattersley and Maggie Shepherd. Final reflections on making the One in Six billion podcast. 25:29

2M ago25:29

25:29

In the final episode of the One in Six Billion podcast Andrew and Maggie reflect with producer Steve Chapman on the fun they have had making 51 podcasts with 70 guests in the past 2 years. Send us a textBy Andrew Hattersley and Maggie Shepherd

1
Church of Norway Apologizes, The Tech Right's Phyllis Schlafly, The Rachel and I'll See You At The Botanical Garden, Bitch. 1:09:37

2M ago1:09:37

1:09:37

This week Erin and Bryan are both enjoying the fall weather in Santa Fe and New York, sharing some recent restaurant experiences, what it's like being interrupted by Boomers, and reminisce about The Rachel haircut. Bryan discusses The Church of Norway apologizing to the LGBTQ+ community for decades of discrimination, and for causing shame, harm and…

1
Special Edition: The Cardiovascular Outcome Trials – Origin and Perspective 31:05

3M ago31:05

31:05

In this special series on The Cardiovascular Outcome Trials our host, Dr. Neil Skolnik will discuss the history and importance of the Cardiovascular Outcome Trials for diabetes medications . In Part 1 we discuss an historical perspective with Dr. Steven Nissen and how this has lead to the CVOTs that change the way we practice from EMPA-REG in 2015 …

1
Vikings Gay Cheerleaders, Supreme Court Reviewing Conversion Therapy Ban, Paul McCartney's Got Back and The Land 1:03:31

3M ago1:03:31

1:03:31

This week Erin tells us all about her husband Alé's Paul McCartney VIP concert experience, and Bryan had some trouble offloading a ticket for the LA Philharmonic. Erin discusses the backlash to the two new gay male cheerleaders for the Minnesota Vikings squad and how their casting threatens toxic masculinity in the world of football. Bryan covers t…

1
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer 26:10

3M ago26:10

26:10

In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative early breast cancer including insights on identifying high-risk disease considering clinical/pathological factors and gene expression assays and answering healthcare professional questions on h…

1
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer 23:57

3M ago23:57

23:57

In this podcast episode, breast cancer experts Manali Bhave, MD, and Erin F. Cobain, MD, discuss their management of patients with HR-positive/HER2-negative metastatic breast cancer including the current treatment algorithm, implementing genomic testing for assessing molecular resistance and guiding treatment decisions, and answering healthcare pro…

1
Series 4 Episode 8. Rohini Bajekal and Shivani Misra. The challenge of diagnosing monogenic diabetes in South Asians 35:47

2M ago35:47

35:47

Rohini Bajekal describes how she had years of receiving inappropriate lifestyle advice before Glucokinase MODY was diagnosed. Dr Shivani Misra’s research has shown that failure to diagnose monogenic diabetes is even common in South Asians than in the white European population. Send us a textBy Andrew Hattersley and Maggie Shepherd